https://www.carvykti.com/
CARVYKTI® (ciltacabtagene autoleucel) | Official Patient Website
ciltacabtagene autoleucelofficialpatient
https://www.jwtherapeutics.com/en/media/press-release/jw-therapeutics-announces-updated-1-year-follow-up-result-of-relmacabtagene-autoleucel-injection-at-the-24th-annual-meeting-of-the-chinese-society-of-clinical-oncology-csco-1/
JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At...
https://pubmed.ncbi.nlm.nih.gov/36479545/
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted...
Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world...
ciltacabtagene autoleucelfor patientsmultiple myeloma
https://www.tecelra-hcp.com/
TECELRA (afamitresgene autoleucel) HCP Website | TECELRAHCP
TECELRA (afamitresgene autoleucel) TCR T-cell therapy for certain MAGE-A4+ synovial sarcoma patients. See safety info including Boxed Warning about CRS.
afamitresgene autoleucelhcp